Grundemar L, Wahlestedt C, Reis D J
Department of Neurology, Cornell University Medical College, New York, NY.
J Pharmacol Exp Ther. 1991 Aug;258(2):633-8.
Microinjection of neuropeptide Y (NPY) into the nucleus tractus solitarius (NTS) induces an initial and reversible fall in arterial pressure (AP) and heart rate (HR), along with a delayed and long-lasting blockade of cardiovascular responses to L-glutamate (L-Glu) injected into the same site and an inhibition of the baroreflex arc. By injecting NPY-receptor subtype selective agonists and NPY-related peptides into NTS we have sought to characterize the receptors that mediate these responses. Unilateral injections into NTS (9-90 pmol) of NPY as well as the Y1 receptor selective agonist [34Pro]NPY and the Y2 receptor selective fragment NPY 13-36 evoked comparable dose-dependent falls of AP and HR in the anesthetized and paralyzed rat. Injections into NTS of peptide YY or pancreatic polypeptide had no effect. Preinjection of NPY, [34Pro]NPY, NPY 13-36 (all at 90 pmol) as well as norepinephrine (6.7 nmol) virtually abolished the fall in AP and HR evoked by subsequent injections of L-Glu into NTS. Injection of peptide YY or pancreatic polypeptide (both at 90 pmol) did not affect the cardiovascular responses evoked by L-Glu in NTS. Injection of NPY (90 pmol) into the caudal ventrolateral medulla induced a slight fall in AP of -17 +/- 5 mm Hg (P less than .05) and a sustained fall in HR of -44 +/- 8 beats per min (P less than .01). Injection of NPY also abolished the fall in HR and AP evoked by L-Glu in the caudal ventrolateral medulla. The profile of the cardiovascular effects elicited by the NPY-related peptides in NTS does not correspond to either of the Y1 or the Y2 receptor subtypes. The findings suggest that NPY acts on an atypical receptor in NTS to lower AP and HR. Moreover, this receptor may also interfere with the L-Glu-evoked neurotransmission in the NTS. Finally, norepinephrine shared with NPY the ability to inhibit L-Glu-evoked responses in NTS; however, a much higher dose of norepinephrine (than NPY) was required.
将神经肽Y(NPY)微量注射到孤束核(NTS)中会导致动脉血压(AP)和心率(HR)最初出现可逆性下降,同时对注射到同一部位的L-谷氨酸(L-Glu)引起的心血管反应产生延迟且持久的阻断作用,并抑制压力感受性反射弧。通过将NPY受体亚型选择性激动剂和NPY相关肽注射到NTS中,我们试图确定介导这些反应的受体。在麻醉和麻痹的大鼠中,向NTS单侧注射NPY(9-90皮摩尔)以及Y1受体选择性激动剂[34Pro]NPY和Y2受体选择性片段NPY 13-36,均可引起AP和HR类似的剂量依赖性下降。向NTS注射肽YY或胰多肽则无作用。预先注射NPY、[34Pro]NPY、NPY 13-36(均为90皮摩尔)以及去甲肾上腺素(6.7纳摩尔)实际上消除了随后向NTS注射L-Glu所引起的AP和HR下降。注射肽YY或胰多肽(均为90皮摩尔)并不影响L-Glu在NTS中引起的心血管反应。向尾侧腹外侧延髓注射NPY(90皮摩尔)可使AP轻微下降-17±5毫米汞柱(P<0.05),HR持续下降-44±8次/分钟(P<0.01)。注射NPY还消除了L-Glu在尾侧腹外侧延髓中引起的HR和AP下降。NTS中NPY相关肽引起的心血管效应特征与Y1或Y2受体亚型均不相符。这些发现表明,NPY作用于NTS中的一种非典型受体以降低AP和HR。此外,该受体可能还会干扰NTS中L-Glu诱发的神经传递。最后,去甲肾上腺素与NPY一样具有抑制NTS中L-Glu诱发反应的能力;然而,所需去甲肾上腺素的剂量比NPY高得多。